NO176082C - Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel - Google Patents

Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel

Info

Publication number: NO176082C
Authority: NO; Norway
Prior art keywords: preparation; percutaneous delivery; bunazosin; pharmaceutical preparation; preparation containing
Prior art date: 1988-11-11

Application number

NO894465A

Other languages

English (en)

Other versions

NO176082B (no

NO894465L (no

NO894465D0 (no

Inventor

Mitsuhiro Yoshida

Hiroyuki Fujimori

Hidenori Asakawa

Masayoshi Kasai

Masanori Kayano

Shigemitsu Osawa

Original Assignee

Eisai Co Ltd

Sansho Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-11-11

Filing date

1989-11-09

Publication date

1995-02-01

1989-11-09 Application filed by Eisai Co Ltd, Sansho Co filed Critical Eisai Co Ltd

1989-11-09 Publication of NO894465D0 publication Critical patent/NO894465D0/no

1990-05-14 Publication of NO894465L publication Critical patent/NO894465L/no

1994-10-24 Publication of NO176082B publication Critical patent/NO176082B/no

1995-02-01 Publication of NO176082C publication Critical patent/NO176082C/no

Links

RHLJLALHBZGAFM-UHFFFAOYSA-N Bunazosinum Chemical compound C1CN(C(=O)CCC)CCCN1C1=NC(N)=C(C=C(OC)C(OC)=C2)C2=N1 RHLJLALHBZGAFM-UHFFFAOYSA-N 0.000 title abstract 2
229960002467 bunazosin Drugs 0.000 title abstract 2
238000000034 method Methods 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
125000004432 carbon atom Chemical group C* 0.000 abstract 2
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 1
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract 1
235000014113 dietary fatty acids Nutrition 0.000 abstract 1
229930195729 fatty acid Natural products 0.000 abstract 1
239000000194 fatty acid Substances 0.000 abstract 1
150000004665 fatty acids Chemical class 0.000 abstract 1
150000003903 lactic acid esters Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

NO894465A 1988-11-11 1989-11-09 Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel NO176082C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP63285428A JP2794022B2 (ja)	1988-11-11	1988-11-11	ブナゾシン或いはその塩類含有経皮適用製剤

Publications (4)

Publication Number	Publication Date
NO894465D0 NO894465D0 (no)	1989-11-09
NO894465L NO894465L (no)	1990-05-14
NO176082B NO176082B (no)	1994-10-24
NO176082C true NO176082C (no)	1995-02-01

Family

ID=17691396

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO894465A NO176082C (no)	1988-11-11	1989-11-09	Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel

Country Status (11)

Country	Link
US (1)	US5041437A (no)
EP (1)	EP0368339B1 (no)
JP (1)	JP2794022B2 (no)
AT (1)	ATE90873T1 (no)
AU (1)	AU615115B2 (no)
CA (1)	CA2001574A1 (no)
DE (1)	DE68907312T2 (no)
DK (1)	DK559989A (no)
ES (1)	ES2057064T3 (no)
FI (1)	FI92149C (no)
NO (1)	NO176082C (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH06509099A (ja) *	1991-07-03	1994-10-13	サノ・コーポレーシヨン	ジクロフエナツクの経皮デリバリーに対する組成物及び方法
US5900250A (en) *	1992-05-13	1999-05-04	Alza Corporation	Monoglyceride/lactate ester permeation enhancer for oxybutnin
CA2165802A1 (en) *	1993-09-29	1995-04-06	Eun Soo Lee	Monoglyceride/lactate ester permeation enhancer for oxybutynin
US5420106A (en) *	1994-03-22	1995-05-30	Bristol-Myers Squibb Company	Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
US5503843A (en) *	1994-04-22	1996-04-02	Flora Inc.	Transdermal delivery of alpha adrenoceptor blocking agents
GB2301878A (en) *	1995-06-06	1996-12-18	Hardware & Systems Patents Ltd	Ventilator:mounting
US7258869B1 (en)	1999-02-08	2007-08-21	Alza Corporation	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
EP1152749B1 (en) †	1999-02-08	2006-04-12	ALZA Corporation	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7179483B2 (en)	2000-04-26	2007-02-20	Watson Pharmaceuticals, Inc.	Compositions and methods for transdermal oxybutynin therapy
US7731947B2 (en)	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
MX2008014870A (es)	2006-05-30	2009-02-12	Intarcia Therapeutics Inc	Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
EP2049081B1 (en)	2006-08-09	2012-11-14	Intarcia Therapeutics, Inc.	Osmotic delivery systems and piston assemblies
HRP20130259T1 (hr)	2007-04-23	2013-04-30	Intarcia Therapeutics, Inc.	Suspenzijske formulacije inzulinotropnih peptida i njihove uporabe
DK2240155T3 (da)	2008-02-13	2012-09-17	Intarcia Therapeutics Inc	Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
SMT201700583T1 (it)	2009-09-28	2018-01-11	Intarcia Therapeutics Inc	Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en)	2015-06-03	2021-02-23	Intarcia Therapeutics, Inc.	Implant placement and removal systems
RU2760007C2 (ru)	2016-05-16	2021-11-22	Интарсия Терапьютикс, Инк.	Полипептиды, селективные к рецепторам глюкагона, и способы их применения
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
CN110225762A (zh)	2017-01-03	2019-09-10	因塔西亚制药公司	包括glp-1受体激动剂的连续施用和药物的共同施用的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4377581A (en) *	1980-03-03	1983-03-22	Pfizer Inc.	Chloro- and alkoxy-substituted-2,4-diaminoquinazolines
JPS58225009A (ja) *	1982-06-23	1983-12-27	Shionogi & Co Ltd	コルチコステロイド外用製剤
JPS6122512A (ja) *	1984-07-06	1986-01-31	ヤマハ株式会社	ワイヤハ−ネス製造システム用コネクタ−配置ヘッド
JPS6169721A (ja) *	1984-09-13	1986-04-10	Kao Corp	抗真菌組成物
US4925837A (en) *	1984-09-14	1990-05-15	Synthelabo	Pharmaceutical compositions
JPS61225122A (ja) *	1985-03-30	1986-10-06	Eisai Co Ltd	キナツオリン系化合物含有組成物
JPH0735332B2 (ja) *	1986-02-25	1995-04-19	久光製薬株式会社	外用クリ−ム製剤
JP2521091B2 (ja) *	1986-06-18	1996-07-31	日研化学株式会社	カテコ−ルアミン類の外用製剤
JPH0816066B2 (ja) *	1986-07-18	1996-02-21	エーザイ株式会社	持続性薬効製剤
US4766842A (en) *	1987-04-29	1988-08-30	Jon Long	Method and means for wave soldering of leads of an integrated circuit package

1988
- 1988-11-11 JP JP63285428A patent/JP2794022B2/ja not_active Expired - Fee Related
1989
- 1989-10-24 FI FI895045A patent/FI92149C/fi not_active IP Right Cessation
- 1989-10-26 CA CA002001574A patent/CA2001574A1/en not_active Abandoned
- 1989-10-27 AU AU43845/89A patent/AU615115B2/en not_active Ceased
- 1989-10-27 US US07/428,240 patent/US5041437A/en not_active Expired - Fee Related
- 1989-11-09 NO NO894465A patent/NO176082C/no unknown
- 1989-11-09 DK DK559989A patent/DK559989A/da not_active Application Discontinuation
- 1989-11-10 DE DE89120888T patent/DE68907312T2/de not_active Expired - Fee Related
- 1989-11-10 ES ES89120888T patent/ES2057064T3/es not_active Expired - Lifetime
- 1989-11-10 AT AT89120888T patent/ATE90873T1/de not_active IP Right Cessation
- 1989-11-10 EP EP89120888A patent/EP0368339B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US5041437A (en)	1991-08-20
FI895045A0 (fi)	1989-10-24
EP0368339A3 (en)	1990-12-19
DK559989A (da)	1990-05-12
AU4384589A (en)	1990-05-17
ES2057064T3 (es)	1994-10-16
FI92149B (fi)	1994-06-30
ATE90873T1 (de)	1993-07-15
JPH02131426A (ja)	1990-05-21
AU615115B2 (en)	1991-09-19
EP0368339A2 (en)	1990-05-16
DK559989D0 (da)	1989-11-09
EP0368339B1 (en)	1993-06-23
CA2001574A1 (en)	1990-05-11
JP2794022B2 (ja)	1998-09-03
DE68907312D1 (de)	1993-07-29
DE68907312T2 (de)	1993-11-25
FI92149C (fi)	1994-10-10
NO176082B (no)	1994-10-24
NO894465L (no)	1990-05-14
NO894465D0 (no)	1989-11-09

Publication	Publication Date	Title
NO176082C (no)	1995-02-01	Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel
IE861813L (en)	1987-01-08	New Polysaccharide Esters and their Salts
ATE15443T1 (de)	1985-09-15	Essbare, pharmazeutische zusammensetzungen und verfahren zur herstellung.
PH30120A (en)	1996-12-27	Stable pharmaceutical composition of fumagillol derivatives
NO305932B1 (no)	1999-08-23	Farmasoeytisk akseptabel L-DOPA-etylesterbase, et farmasoeytisk preparat innneholdende base, en fremgangsmåte for fremstilling av preparatet samt L-DOPA-etylesteren
HU905827D0 (en)	1991-03-28	Process for producing 4-hydroxi-tetrahydro-pyrane-2-one derivatives as well as corresponding dihydroxi-carboxylic acid derivatives and pharmaceutical preparatives containing these compounds
YU221889A (en)	1992-05-28	Process for producing new pharmaceutical mixture
WO1987004926A3 (en)	1988-05-19	Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
NO932236L (no)	1993-06-17	Farmasoeytisk preparat inneholdende probukol med forhoeyet biotilgjengelighet
ATE98486T1 (de)	1994-01-15	Selbstklebende vorrichtung zur transdermalen verabreichung eines wirkstoffs.
JPS5663956A (en)	1981-05-30	Piperidine derivative of 455dialkyll33hydroxyy pyrrolee22carboxylic ester its manufacture and medicine containing it
ATE212840T1 (de)	2002-02-15	Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
IL82639A0 (en)	1987-11-30	Transdermal pharmaceutical composition
HK8994A (en)	1994-02-04	Medicament for treatment of pregnancy-induced hypertension
JPS5640607A (en)	1981-04-16	Drug composition
JPS57140783A (en)	1982-08-31	1-benzyl-4-(4-(2-pyrimidinylamino)benzyl)-2, 3-dioxopiperazine derivative and its salt, their preparation, and carcinostatic agent containing the same
IT1214658B (it)	1990-01-18	Esteri polisaccaridici e loro sali
KR890001565A (ko)	1989-03-27	활성성분으로 3- 벤조일옥시-1,3,5(10)-에스트라트리엔-17-[4-(p-비스(2-클로로에틸) 아미노)페닐)부타노일옥시]아세테이트를 함유하는 주사약
JPS56123919A (en)	1981-09-29	Remedy and preventive for diabetes
AU1257888A (en)	1989-01-12	Stable, injectable solutions of vinca dimer salts